PRESS RELEASE WASHINGTON.

Scarsi received her PharmD from Drake University College of Pharmacy and Wellness Sciences and earned her Master of Science level in Clinical Investigation from Northwestern University. After completing a PGY1 residency at Northwestern Memorial Hospital , she offered as an infectious diseases scientific pharmacist. After 5 years of HIV-focused practice at NMH, Scarsi joined up with the faculty at Northwestern University Feinberg School of Medication and began working with the President’s Crisis Plan for AIDS Comfort program in Nigeria. Through her part with PEPFAR and additional international collaborations, Scarsi provides education and schooling to healthcare provid­ers, thus building capability of HIV treatment programs in sub-Saharan Africa.Christopher Sweeney, an associate professor of medication at Harvard Medical College. For 50 years, hormone therapy has been the standard care for these individuals, he said. Adding chemotherapy to hormone therapy is worth doing because even though it’s not a cure, it does improve survival and quality of life, Sweeney said. The scholarly study was funded by the U.S. National Tumor Institute, and the statement was published Aug. 5 on the web in the brand new England Journal of Medicine. For the study, Sweeney and colleagues assigned 790 guys with prostate cancer randomly, average age 63, to chemotherapy as well as hormone hormone or therapy therapy alone.

You Might Also Like